Literature DB >> 10632963

Growth hormone size variants: changes in the pituitary during development of the chicken.

C Arámburo1, M Luna, M Carranza, M Reyes, H Martínez-Coria, C G Scanes.   

Abstract

There is considerable evidence for the existence of structural variants of growth hormone (GH). The chicken is a useful model for investigating GH heterogeneity as both size and charge immunoreactive-(ir) variants have been observed in the pituitary and plasma. The present study examined the size distribution of ir-GH in the pituitary gland of chicken, from late embryogenesis through adulthood. Pituitaries were homogenized in the presence of protease inhibitor, and the GH size variants were separated by SDS-PAGE, transferred by Western blotting, immunostained with a specific antiserum to chicken GH, and quantitated by chemiluminescence followed by laser densitometry (chemiluminescent assay). Under nonreducing conditions ir-GH bands of 15, 22, 25, 44, 50, 66, 80, 98, 105 and >110 kDa were observed. Both the relative proportion of the GH size variants and the total pituitary content varied with developmental stage and age. The proportion of the 15-kDa fragment was greatest in the embryonic stage, and then it decreased. The proportion of the monomeric 22-kDa form was lowest at 18 days of embryogenesis (dE) and highest at 20 dE. In contrast, the high MW forms (>/=66 kDa) were lowest in embryos, and they increased (P < 0.05) after hatching. The 22-, 44-, 66-, and 80-kDa forms were assayed for activity by radioreceptor assay following isolation by semipreparative SDS-PAGE. Only the 22-kDa GH variant showed radioreceptor activity. Under reducing conditions for SDS-PAGE, ir-GH bands of 13, 15, 18, 23, 26, 36, 39, 44, 48, 59 and 72 kDa were oberved, but most of the high MW form disappeared. There was a concomitant increase in the proportion of the monomeric band and of several submonomeric forms. The present data indicate that the expression, processing, and/or release of some if not all size variants are under some differential control during growth and development of the chicken.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632963     DOI: 10.1046/j.1525-1373.2000.22309.x

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

1.  Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken.

Authors:  H C Liu; H J Kung; J E Fulton; R W Morgan; H H Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Characterization of a bioactive 15 kDa fragment produced by proteolytic cleavage of chicken growth hormone.

Authors:  C Arámburo; M Carranza; M Reyes; M Luna; H Martinez-Coria; L Berúmen; C G Scanes
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

3.  O-Glycosylated 24 kDa human growth hormone has a mucin-like biantennary disialylated tetrasaccharide attached at Thr-60.

Authors:  Juan J Bustamante; Leticia Gonzalez; Christopher A Carroll; Susan T Weintraub; Roberto M Aguilar; Jesus Muñoz; Andrew O Martinez; Luis S Haro
Journal:  Proteomics       Date:  2009-07       Impact factor: 3.984

4.  Growth hormone localization in the neural retina and retinal pigmented epithelium of embryonic chicks.

Authors:  Steve Harvey; Mia Kakebeeke; Esmond J Sanders
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Differential secretion of chicken growth hormone variants after growth hormone-releasing hormone stimulation in vitro.

Authors:  Hilda Martínez-Coria; L Javier López-Rosales; Martha Carranza; Laura Berumen; Maricela Luna; Carlos Arámburo
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.